Position in NVS
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$2,599,201
+$485,905 QoQ
Shares Held
16,585
+19.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.62%
of 13F equity value
Holder Rank
#381
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Ipswich Investment Management Co., Inc. holds $39,266,096 across 11 Drug Manufacturers - General names. NVS ranks #6 (6.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
37,293 | $9,471,303 | |
| 2 | LLY |
ELI LILLY & Co
|
6,727 | $8,068,566 | |
| 3 | MRK |
Merck & Co., Inc.
|
46,912 | $6,028,192 | |
| 4 | AMGN |
Amgen Inc
|
15,234 | $5,516,536 | |
| 5 | ABBV |
AbbVie Inc.
|
11,896 | $2,993,509 | |
| 6 | NVS |
Novartis AG
This page
|
16,585 | $2,599,201 | |
| 7 | NVO |
Novo Nordisk A S
|
50,411 | $2,416,703 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
17,229 | $992,734 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,599,201 | 16,585 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $2,113,296 | 13,835 | Shares | Sole | 2026-04-10 | |
| 2025-12-31 | $2,358,542 | 17,107 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $2,207,266 | 17,212 | Shares | Sole | 2025-10-08 | |
| 2025-06-30 | $2,193,548 | 18,127 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $2,169,623 | 19,462 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $1,968,289 | 20,227 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $2,326,509 | 20,227 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $2,153,792 | 20,231 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $1,956,557 | 20,227 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $2,042,320 | 20,227 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $2,060,322 | 20,227 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $1,978,542 | 19,607 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $1,932,644 | 21,007 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $1,769,675 | 19,507 | Shares | Sole | 2023-02-01 | |
| 2022-09-30 | $1,973,979 | 25,970 | Shares | Sole | 2022-10-11 | |
| 2022-06-30 | $2,370,052 | 28,038 | Shares | Sole | 2022-07-26 | |
| 2022-03-31 | $2,640,748 | 30,094 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $2,492,370 | 28,494 | Shares | Sole | 2022-01-24 | |
| 2021-09-30 | $2,054,231 | 25,119 | Shares | Sole | 2021-10-07 | |
| 2021-06-30 | $2,337,477 | 25,619 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $2,195,895 | 25,689 | Shares | Sole | 2021-04-09 | |
| 2020-12-31 | $2,480,203 | 26,265 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $2,309,918 | 26,563 | Shares | Sole | 2020-10-06 | |
| 2020-06-30 | $2,328,746 | 26,663 | Shares | Sole | 2020-07-09 | |
| 2020-03-31 | $2,198,364 | 26,663 | Shares | Sole | 2020-04-09 | |
| No filing history on record for this holder in this stock. | ||||||